Clinical Trial Update: Safety Study of GCS-100 to Treat Chronic Kidney Disease [Phase 1]

View source ↗

Summary

A Phase 1 safety study evaluating GCS-100 for chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• GCS-100

Snippet

Sponsor: La Jolla Pharmaceutical Company | Conditions: Chronic Kidney Disease | Phase 1 | Status: COMPLETED